Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.
作者信息
Joseph R R, Belpomme D, Mathé G
出版信息
Br J Cancer. 1976 May;33(5):567-70. doi: 10.1038/bjc.1976.91.
Abstract
摘要
相似文献
1
Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.长期免疫治疗缓解期急性淋巴细胞白血病中“无功能”细胞增加。
Br J Cancer. 1976 May;33(5):567-70. doi: 10.1038/bjc.1976.91.
2
Immunotherapy in previously treated acute lymphatic leukemia.
Natl Cancer Inst Monogr. 1973 Dec;39:177-87.
3
BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Natl Cancer Inst Monogr. 1973 Dec;39:165-75.
4
The place of immunological methods of treatment in the management of acute leukaemia.免疫治疗方法在急性白血病治疗中的地位。
Hamatol Bluttransfus. 1976;19:297-304. doi: 10.1007/978-3-642-87524-3_31.
5
Increase in "Null" cells in acute lymphocytic leukemia in remission on long-term immunotherapy.长期免疫治疗缓解期急性淋巴细胞白血病中“无标记”细胞增加。
Recent Results Cancer Res. 1976(56):72-8. doi: 10.1007/978-3-642-81049-7_10.
6
Are circulating null cells in patients submitted to long-term immunotherapy, related to K cells?
Eur J Cancer (1965). 1977 Apr-May;13(4-5):441-4. doi: 10.1016/0014-2964(77)90100-1.
7
Immune complexes in children with leukemia: relationship to disease characteristics and to antibody response to Mycobacterium bovis (BCG) in patients receiving BCG immunotherapy.白血病患儿中的免疫复合物：与疾病特征以及接受卡介苗免疫治疗患者对牛分枝杆菌（卡介苗）抗体反应的关系。
Cancer. 1980 Feb;45(3):460-8. doi: 10.1002/1097-0142(19800201)45:3<460::aid-cncr2820450309>3.0.co;2-3.
8
BCG in the treatment of acute lymphocytic leukemia.
Blood. 1975 Sep;46(3):431-42.
9
Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function.
Int J Cancer. 1975 Jul 15;16(1):103-12. doi: 10.1002/ijc.2910160112.
10
New results of active immunotherapy of acute lymphoid leukaemia.
Bibl Haematol. 1973;39:1115-24. doi: 10.1159/000427817.
引用本文的文献
1
Chemotherapy, a double agent in respect of immune functions.化疗，在免疫功能方面是一把双刃剑。
Cancer Chemother Pharmacol. 1978;1(2):65-8. doi: 10.1007/BF00254037.
2
Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations.肾移植受者移植后T、B淋巴细胞亚群及裸淋巴细胞亚群的监测
Clin Exp Immunol. 1977 Apr;28(1):123-9.
本文引用的文献
1
The role of the reticuloendothelial system in the host reaction to neoplasia.网状内皮系统在宿主对肿瘤形成的反应中的作用。
Cancer Res. 1961 Oct;21:1281-300.
2
3
Impaired lymphocyte function in aged humans.老年人淋巴细胞功能受损。
J Clin Invest. 1974 Jan;53(1):99-104. doi: 10.1172/JCI107565.
4
Immunochemotherapy of human cancer.人类癌症的免疫化学疗法。
Semin Oncol. 1974 Dec;1(4):409-23.
5
Use of BCG in the treatment of human neoplasms: a review.
Semin Oncol. 1974 Dec;1(4):337-50.
6
7
Rosette-forming T cells in human peripheral blood at different ages.
Cell Immunol. 1974 May;12(2):323-5. doi: 10.1016/0008-8749(74)90085-9.
8
Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell.由“无标记”淋巴细胞引起的抗体依赖性细胞介导的细胞毒性。
Nat New Biol. 1973 Mar 28;242(117):111-3. doi: 10.1038/newbio242111a0.
9
Editorial: How clinically useful is T and B cell quantitation?
Ann Intern Med. 1974 Jun;80(6):765-7. doi: 10.7326/0003-4819-80-6-765.
10
Active immunotherapy for acute lymphoblastic leukaemia.急性淋巴细胞白血病的主动免疫疗法。
Lancet. 1969 Apr 5;1(7597):697-9. doi: 10.1016/s0140-6736(69)92648-8.
Zotero 插件